Maxigen Biotech Inc
TWSE:1783

Watchlist Manager
Maxigen Biotech Inc Logo
Maxigen Biotech Inc
TWSE:1783
Watchlist
Price: 46.6 TWD 0.32% Market Closed
Market Cap: 4.2B TWD

Wall Street
Price Targets

Price Targets Summary
Maxigen Biotech Inc

There are no price targets for Maxigen Biotech Inc.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Maxigen Biotech Inc Competitors:
Price Targets
ITP
Interparfums SA
35% Upside
300957
Yunnan Botanee Bio-Technology Group Co Ltd
6% Upside
LFMD
LifeMD Inc
146% Upside
300740
SYoung Group Co Ltd
7% Upside
090430
AmorePacific Corp
34% Upside
603896
Zhejiang Shouxiangu Pharmaceutical Co Ltd
30% Upside
4922
Kose Corp
8% Upside
SKIN
Beauty Health Co
26% Upside

Revenue
Forecast

Revenue Estimate
Maxigen Biotech Inc

For the last 13 years the compound annual growth rate for Maxigen Biotech Inc's revenue is 11%. The projected CAGR for the next 6 years is -6%.

11%
Past Growth
-6%
Estimated Growth
Estimates Accuracy
-9%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Maxigen Biotech Inc

The compound annual growth rate of Maxigen Biotech Inc's operating income for the next 6 years is -16%.

N/A
Past Growth
-16%
Estimated Growth
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Maxigen Biotech Inc

The compound annual growth rate of Maxigen Biotech Inc's net income for the next 6 years is -14%.

N/A
Past Growth
-14%
Estimated Growth
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Maxigen Biotech Inc's stock price target?
Not Available

Maxigen Biotech Inc doesn't have any price targets made by Wall Street professionals.

What is Maxigen Biotech Inc's Revenue forecast?
Projected CAGR
-6%

For the last 13 years the compound annual growth rate for Maxigen Biotech Inc's revenue is 11%. The projected CAGR for the next 6 years is -6%.

What is Maxigen Biotech Inc's Operating Income forecast?
Projected CAGR
-16%

The compound annual growth rate of Maxigen Biotech Inc's operating income for the next 6 years is -16%.

What is Maxigen Biotech Inc's Net Income forecast?
Projected CAGR
-14%

The compound annual growth rate of Maxigen Biotech Inc's net income for the next 6 years is -14%.

Back to Top